BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA
186 results:

  • 1. The relationship between long non-coding gene
    Han L; Liu J; Shataer M; Wu C; Niyazi M
    Cancer Biol Ther; 2024 Dec; 25(1):2322207. PubMed ID: 38465665
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between Endometriosis and the Risk of Ovarian, Endometrial, Cervical, and Breast cancer: A Population-Based Study from the U.S. National Inpatient Sample 2016-2019.
    Al-Badawi IA; Abu-Zaid A; Alomar O; Alsabban M; Alsehaimi SO; Alqarni SMS; Alabdrabalamir SN; Baradwan S; Al Baalharith M; AlOdaini AA; Saleh SAK; Adly HM; Bukhari IA; Salem H
    Curr Oncol; 2024 Jan; 31(1):472-481. PubMed ID: 38248117
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
    Oštrbenk Valenčak A; Cuschieri K; Connor L; Zore A; Smrkolj Š; Poljak M
    J Clin Virol; 2024 Feb; 170():105638. PubMed ID: 38183829
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical Characteristics and Detection Sensitivity of Cervical cancer Screening in Vaginal Intraepithelial Neoplasia.
    Chen Y; Chen Q; Xue H; Zheng J; Chen J; Zheng X
    J Low Genit Tract Dis; 2024 Apr; 28(2):137-142. PubMed ID: 38109483
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of normalization of postoperative carbohydrate antigen 125 levels with treatment failure following uterine artery embolization for adenomyosis.
    Liu S; Peng C; Wang Z; Zhou X; Zhang S; Li G; Yang B
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2753-2760. PubMed ID: 37614048
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Nomogram for Predicting Progression-free Survival in Patients with Endometrial cancer.
    Wang Z; Zhao Z; Li W; Bao X; Liu T; Yang X
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e516-e527. PubMed ID: 37230875
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.
    Handley KF; Mehta S; Martin AL; Biswas S; Maharaj K; Nagy MZ; Mine JA; Cortina C; Yu X; Sprenger K; Mandal G; Innamarato P; Powers JJ; Harro CM; Chaurio RA; Anadon CM; Shahzad MM; Flores I; Conejo-Garcia JR
    Gynecol Oncol; 2023 Jun; 173():114-121. PubMed ID: 37121178
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
    Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
    J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic value of T2 and diffusion-weighted imaging (DWI) in local staging of endometrial cancer.
    Arian A; Ahmadi E; Gity M; Setayeshpour B; Delazar S
    J Med Imaging Radiat Sci; 2023 Jun; 54(2):265-272. PubMed ID: 36725387
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of the one-step nucleic acid amplification assay for detecting lymph node metastasis in patients with cervical and endometrial cancer: A multicenter prospective study.
    Togami S; Tanimoto A; Yanazume S; Tokunaga H; Nagai T; Watanabe M; Yahata H; Asanoma K; Yamamoto H; Tanaka T; Ohmichi M; Yamada T; Todo Y; Yamada R; Kato H; Yamagami W; Masuda K; Kawaida M; Niikura H; Moriya T; Kobayashi H
    Gynecol Oncol; 2023 Mar; 170():70-76. PubMed ID: 36638744
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.
    Yap S; Vassallo A; Goldsbury D; O'Connell DL; Brand A; Emery J; DeFazio A; Canfell K; Steinberg J
    Cancer Causes Control; 2023 Jan; 34(1):47-58. PubMed ID: 36209449
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Value of colposcopy with dynamic spectral imaging in the detection and evolution of high-grade cervical lesions.
    Coronado Martín PJ; González González V; Fasero Láiz M
    Expert Rev Med Devices; 2022 Jun; 19(6):525-532. PubMed ID: 35858486
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Amide Proton Transfer-Weighted Imaging Combined With Intravoxel Incoherent Motion for Evaluating Microsatellite Instability in Endometrial cancer.
    Ma C; Tian S; Song Q; Chen L; Meng X; Wang N; Lin L; Wang J; Liu A; Song Q
    J Magn Reson Imaging; 2023 Feb; 57(2):493-505. PubMed ID: 35735273
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.
    Lim N; Hickey M; Young GP; Macrae FA; Kelly C
    Int J Gynecol Cancer; 2022 May; 32(5):646-655. PubMed ID: 35437274
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study.
    Salvo G; Jhingran A; Ramalingam P; Legarreta AF; Bhosale P; Gonzales NR; Chisholm GB; Frumovitz M
    Gynecol Oncol; 2022 Jun; 165(3):530-537. PubMed ID: 35396134
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effectiveness and immune responses of focused ultrasound ablation for cervical intraepithelial neoplasia.
    Zeng H; Liu M; Xiao L; Zhang X; Feng Q; Chang S
    Int J Hyperthermia; 2022; 39(1):539-546. PubMed ID: 35313793
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Beyond T Cells: iga Incites Immune Recognition in Endometrial cancer.
    Osorio JC; Zamarin D
    Cancer Res; 2022 Mar; 82(5):766-768. PubMed ID: 35247898
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. iga-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial cancer.
    Mandal G; Biswas S; Anadon CM; Yu X; Gatenbee CD; Prabhakaran S; Payne KK; Chaurio RA; Martin A; Innamarato P; Moran C; Powers JJ; Harro CM; Mine JA; Sprenger KB; Rigolizzo KE; Wang X; Curiel TJ; Rodriguez PC; Anderson AR; Saglam O; Conejo-Garcia JR
    Cancer Res; 2022 Mar; 82(5):859-871. PubMed ID: 34949671
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial cancer Recurrence].
    Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery.
    Livson S; Jarva H; Kalliala I; Lokki AI; Heikkinen-Eloranta J; Nieminen P; Meri S
    Front Immunol; 2020; 11():563073. PubMed ID: 33505390
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.